Immune-deficient subjects or those with mucosal disease may experience serious adverse effects
- SCIENTIFIC NAMES: Saccharomyces boulardii; Saccharomyces cerevisiae
- INDICATIONS: Diarrhea, rotaviral diarrhea, irritable bowel syndrome, Crohn's disease, ulcerative colitis, urinary tract infections, vaginal infections, acne, premenstrual syndrome, furunculosis
- SYNONYM: Saccharomycetaceae
- CLASS: Immunomodulator, Probiotic
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
MAO inhibitors
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of probiotics in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 07/31/2023
